Literature DB >> 7130828

Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight.

R M Bertina, I K Van Der Linden.   

Abstract

A genetic variant of blood coagulation factor IX has been isolated from the plasma of a patient with severe hemophilia B (congenital factor IX deficiency). The isolated variant--factor IX Zutphen--has a strongly reduced affinity for binding of Ca2+, it cannot be cleaved proteolytically by factor XIa, and it has a molecular weight of about 90,000, which is much higher than the 65,000 found for normal factor IX and acarboxy factor IX. Available data indicate that these unique properties of factor IX Zutphen are connected with the presence of an extra polypeptide (molecular weight 33,000) that is linked to the factor IX molecule by a disulfide bond and thus prevents effective binding of Ca2+ or factor XIa. Such a model might explain the extremely low specific coagulant activity of factor IX Zutphen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7130828

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  2 in total

1.  Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site.

Authors:  P Usharani; B J Warn-Cramer; C K Kasper; S P Bajaj
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

2.  Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation.

Authors:  E G Wojcik; M van den Berg; I K van der Linden; S R Poort; R Cupers; R M Bertina
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.